ANN ARBOR, Mich., Nov. 5 /PRNewswire/ -- Assay Designs, Inc., a leading provider of immunoassay kits, antibodies, and reagents to the life science and translational research markets, has announced a strategic agreement with Abnova Corporation of Taiwan. The agreement enables Assay Designs to distribute approximately 3,200 of Abnova's highly characterized monoclonal antibodies to their U.S. and Canadian customers. This major product addition expands Assay Designs' current product portfolio to include over 5,300 reagents for important research areas such as cell signaling, cellular stress, neuroscience, and inflammation.
"This new partnership with Abnova expands our current product portfolio tremendously with high quality monoclonals for a broad range of applications and research areas," stated Dan Calvo, CEO of Assay Designs. "Abnova's capacity to develop and produce antibodies is very complementary to our current antibody and immunoassay businesses, and affords our customer base easy access to their most highly characterized monoclonals for applications such as ELISA, immunohistochemistry, and immunofluorescence as well as western blotting."
Abnova's mission is to be the world's largest antibody distributor. They have the capacity of generating 500 mouse monoclonal antibodies and 500 rabbit polyclonal antibodies per month. "We are very pleased to be collaborating with Assay Designs on broadening the exposure and accessibility of Abnova antibody and proteins products in the research market," states Wilbur Huang, CEO of Abnova. "Moreover, Assay Designs' expertise in immunoassay and system development highly complements Abnova's capability in industrial-scale antibody manufacturing based on 'one gene one antibody' translation of the human genome. Assay Designs and Abnova will work closely together to realize next generation of analytical products which will accelerate the translational research in the proteomics era."
About Assay Designs, Inc.
Based in Ann Arbor, MI, Assay Designs develops and manufactures immunoassay (ELISA) kits, luminescent reagents, antibodies, proteins, and extracts used for life sciences research. The company markets these products under the Assay Designs and Stressgen(R) brand names. Researchers use the company's products to detect and quantify molecules that are important in inflammation, cell signaling, and cellular stress. New assay platforms include MultiBead(TM) bead-based multiplex immunoassay kits and ImmunoSet(TM) ELISA development reagents.
About Anbova Corporation
Abnova is a bio-tool proteomic company specializing in automated, high throughput protein expression and antibody production. The system Abnova has developed is a unique combination of world-class technologies and management experience of the IT industry in Taiwan. The company's goal is to vastly expand the scope and availability of bio-tool reagents. As such, it is a taking a genome-wide approach to the production of human recombinant protein and antibody, and is developing a portfolio of integrated and systemized applications including immuno- and multiplex-assays covering protein families that are essential to the drug discovery and diagnostic industries.
CONTACT: Emily Riess, Assay Designs, Inc., +1-800-833-8651,
Web site: http://www.assaydesigns.com/